XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC

Clinical trial NCT06742411 · RECRUITING

Trial details

NCT number: NCT06742411
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric (Stomach) Cancer

Start date: 2024-12-31
Primary completion: 2026-12-31
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.